Use of new and known pyridine or pyrimidine compounds, for the treatment of a disease or condition associated with tankyrase, e.g. cancer selected from e.g. breast, colon, stomach, and liver.

There is a more recent version of this item available.

UNSPECIFIED (2016) Use of new and known pyridine or pyrimidine compounds, for the treatment of a disease or condition associated with tankyrase, e.g. cancer selected from e.g. breast, colon, stomach, and liver. WO2017-GB52624.

More Information

Depositing User: Amit Nathubhai

Identifiers

Item ID: 9803

Identification Number: WO2017-GB52624

URI: http://sure.sunderland.ac.uk/id/eprint/9803

Official URL: https://worldwide.espacenet.com/publicationDetails...

Users with ORCIDS

Catalogue record

Date Deposited: 10 Aug 2018 13:49

Last Modified: 18 Dec 2019 16:07

Contributors

Author:	M.D. Threadgill
Author:	M.D. Lloyd
Author:	A.S. Thompson
Author:	Amit Nathubhai
Author:	H.A. Paine
Author:	E. Kumpan
Author:	P.T Sunderland
Author:	E.C.Y Woon

University Divisions

Faculty of Health Sciences and Wellbeing
Faculty of Health Sciences and Wellbeing > School of Pharmacy and Pharmaceutical Sciences

Subjects

Sciences > Chemistry

Actions (login required)

View Item

Available Versions of this Item

• Use of new and known pyridine or pyrimidine compounds, for the treatment of a disease or condition associated with tankyrase, e.g. cancer selected from e.g. breast, colon, stomach, and liver. (deposited 10 Aug 2018 13:49) [Currently Displayed]
  • New potent and selective tankyrase inhibitors for the treatment of disease or conditions associated with Wnt signalling e.g. colon cancer, prostate cancer, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and type-1/type-2 diabetes. (deposited 10 Aug 2018 13:52)